Krystal Biotech Inc (KRYS)

Total asset turnover

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Revenue (ttm)	US$ in thousands	102,227	56,573	9,365	809	809	0	0	0	0	0	0	0	0	0	0	0	542	1,125	1,342	1,515
Total assets	US$ in thousands	853,296	818,355	790,350	684,026	531,847	558,450	576,379	601,324	616,874	626,295	451,095	443,556	443,018	310,844	311,451	318,145	205,131	209,023	214,232	205,156
Total asset turnover		0.12	0.07	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01

March 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $102,227K ÷ $853,296K
= 0.12

The total asset turnover of Krystal Biotech Inc has shown significant variability over the periods indicated in the data table. The ratio measures the efficiency of the company in generating sales revenue from its total assets.

From Dec 2019 to Mar 2020, the total asset turnover ratio remained low at 0.01, indicating that the company was generating minimal sales revenue relative to its total assets during this period.

However, from Sep 2020 to Mar 2024, there was a notable improvement in the ratio, reaching its peak of 0.12 by Mar 2024. This increase suggests that Krystal Biotech Inc has been more effective in utilizing its total assets to generate sales revenue during these periods.

Overall, the trend in total asset turnover indicates that Krystal Biotech Inc has made progress in enhancing its operational efficiency and effectively utilizing its assets to drive sales revenue generation in recent quarters. Further analysis and monitoring of this ratio will be necessary to assess the company's ongoing performance in this area.